DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Vanderlaan BF. et al.
Cost-effectiveness of 21-gene assay in node-positive, early-stage breast cancer.
The American journal of managed care 2011;
17: 455-464
We do not assume any responsibility for the contents of the web pages of other providers.